| 1 |
Helene Bazin-Lee |
Glaxosmithkline Biologicals Sa |
4 |
| 2 |
David A. Johnson |
Corixa |
2 |
| 3 |
Matt Wilson |
Inc Square, Co. |
1 |
| 3 |
Christina Doriana Groveman |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
1 |
| 3 |
Catharine Mans Bosio |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
1 |
| 3 |
Lynne DePuma Raymond |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
1 |
| 3 |
Juhienah Khalaf |
Omeros |
1 |
| 3 |
Todd Wallace |
AT&T |
1 |
| 3 |
Larry C. Lockhart, Jr. |
— |
1 |
| 3 |
Larry W. McLoskey |
Emc Ip Holding Company |
1 |
| 3 |
Andrew Gregory Hughson |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
1 |
| 3 |
Laura S. BESS |
Glaxosmithkline Biologicals Sa |
1 |
| 3 |
Bradley Richard Groveman |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
1 |
| 3 |
Byron W. Caughey |
US Dept of Health & Human Services |
1 |
| 3 |
Kendal T. Ryter |
University Of Montana |
1 |
| 3 |
Robin M. Ireland |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
1 |
| 3 |
Steven Charles GEIGER |
— |
1 |